KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
Offering extends legacy of SUREtechnology Platform™ for more efficient workflows and simplified processes. Durham, North Carolina (September 12, 2023) – KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, today announced the launch of SUREmAb™,...
Read More